Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2015 | 09-2014 | 09-2013 | 09-2012 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,941 | -58,630 | -31,143 | -21,126 | -3,129 |
| Depreciation Amortization | 3,447 | 2,140 | 1,880 | 1,758 | 260 |
| Accounts receivable | N/A | 75 | -65 | -775 | -736 |
| Accounts payable and accrued liabilities | 2,498 | 1,412 | 322 | 292 | 157 |
| Other Working Capital | 3,408 | 5,005 | 140 | 216 | 7 |
| Other Operating Activity | 16,881 | 14,582 | 9,834 | 4,295 | -4,215 |
| Operating Cash Flow | $-65,708 | $-35,416 | $-19,033 | $-15,340 | $-7,656 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,091 | -34,774 | -9,314 | 509 | N/A |
| PPE Investments | -1,970 | -1,707 | -207 | -189 | -10 |
| Net Acquisitions | -10,000 | N/A | N/A | 121 | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 1,535 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -1,700 |
| Investing Cash Flow | $14,121 | $-36,482 | $-9,521 | $441 | $-175 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -214 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 8 | N/A |
| Debt Repayment | N/A | -225 | -215 | -197 | N/A |
| Common Stock Issued | 505 | 185,520 | 44,506 | 10,958 | 6,226 |
| Financing Cash Flow | $291 | $185,294 | $44,291 | $10,770 | $6,226 |
| Beginning Cash Position | 132,511 | 19,114 | 3,377 | 7,507 | 6,847 |
| End Cash Position | 81,214 | 132,511 | 19,114 | 3,377 | 7,507 |
| Net Cash Flow | $-51,296 | $113,396 | $15,737 | $-4,130 | $660 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,708 | -35,416 | -19,033 | -15,340 | -7,656 |
| Capital Expenditure | -1,971 | -1,717 | -297 | -480 | -10 |
| Free Cash Flow | -67,678 | -37,134 | -19,330 | -15,820 | -7,666 |